Lazard Asset Management’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.12M | Buy |
216,712
+12,314
| +6% | +$177K | ﹤0.01% | 866 |
|
|
2025
Q1 | $1.41M | Buy |
204,398
+172,712
| +545% | +$1.19M | ﹤0.01% | 1080 |
|
|
2024
Q4 | $168K | Buy |
31,686
+14,784
| +87% | +$78.4K | ﹤0.01% | 1657 |
|
|
2024
Q3 | $61K | Buy |
+16,902
| New | +$61K | ﹤0.01% | 1885 |
|
|
2024
Q2 | – | Sell |
-12,592
| Closed | -$43K | – | 2463 |
|
|
2024
Q1 | $43K | Buy |
+12,592
| New | +$43K | ﹤0.01% | 1748 |
|